Cancer

At the Kolling Institute, our cancer research aims to identify and overcome the factors that drive cancer development so that we can improve patient outcomes. We have a number of cancer research teams with different expertise, specialising in chemotherapy resistance, immunotherapies, genetics, epigenetics, diagnostic services and clinical trials. Importantly, these teams have access to an active tissue bank and the latest equipment.

Our cancer research rapidly implements laboratory findings into clinical practice and is supported by the Cancer Institute Translational Centre, Sydney Vital. By bringing together research scientists, clinicians and allied health professionals, we are able to combine innovative and cutting edge research with personalised treatment strategies for cancer patients.

Find out more about:

Bill Walsh Translational Cancer Research Laboratory

Bowel Cancer and Biomarker Research Lab

Breast Cancer Research

Cancer Genetics Laboratory

Kolling Institute Tumour Bank

Events, News and Seminars

Podcast offers insight into the future of healthcare

Podcast offers insight into the future of healthcare

 A fascinating and informative podcast has been launched showcasing groundbreaking research, in..... Read more

Category: Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research, Research Excellence

Celebrating over 100 years of innovation

Celebrating over 100 years of innovation

The inaugural Eva Kolling Research Day was staged within Royal North Shore Hospital, providing the p..... Read more

Category: Awards, Cardiovascular and Renal Research, Funding support, Musculoskeletal Research, Neuroscience and Pain Research, Research Excellence

Improving cancer detection in young people with neurofibromatosis type 1

Improving cancer detection in young people with neurofibromatosis type 1

Researchers from Royal North Shore Hospital and the Kolling Institute will lead Australia’s first st..... Read more

Category: New Treatment, Research Excellence